GAD1 and anxiety disorder: This study does not support the NICE recommendation to use the GAD-2 in early pregnancy, due to its low PPV even for GAD (when applying a cut-off of both ≥3 or≥1 indicating a yes response) and low effectiveness for ‘any anxiety disorder’.